D. Olivieri (Parma, Italy), V. Kolek (Olomouc, Czech Republic)
LATE-BREAKING ABSTRACT: Clinical profile, outcomes, and ivabradine effects in patients with chronic obstructive pulmonary disease and chronic heart failure: the SHIFT trial analysis
M. Lainscak, L. Tavazzi, K. Swedberg, M. Komajda, M. Böhm, J. Borer, M. Robertson, I. Ford (Golnik, Slovenia; Cotignola, Italy; Göteborg, Sweden; Paris, France; Homburg/Saar, Germany; Brooklyn and New York, United States Of America; Glasgow, United Kingdom)
|  |
LATE-BREAKING ABSTRACT: Smoking reduces klotho expression
M. S Patel, A. V Donaldson, S. G Jackson, B. J Bolognese, J. P Foley, P. L Podolin, P. L. Bruijnzeel, N. S Hopkinson, W. D. C Man, P. R Kemp, M. I Polkey (London, United Kingdom; Mölndal, Sweden; King Of Prussia, United States Of America)
| |
Heart rate recovery after 6-min walk test predicts acute exacerbation in COPD
D. A. Rodriguez, A. Arbillaga, E. Kortianou, J. Alison, A. Casas, S. Giavedoni, A. Barberan-Garcia, J. Vilaro, E. Gimeno-Santos, I. Vogiatzis, R. Rabinovich, J. Roca (Barcelona, Spain; Athens, Greece; Sydney, Australia; Bogotá, Colombia; Edimburg, United Kingdom)
| |
Red blood cell distribution with in patients With chronic obstructive pulmonary disease
A. Özgül, E. Seyhan, I. Ömür (Istanbul, Turkey)
| |
COPD and air travel: Does hypoxia-altitude simulation test predict in-flight respiratory symptoms?
A. Edvardsen, M. Ryg, A. AkerØ, C. C. Christensen, O. H. SkjØnsberg (Hakadal, Oslo, Norway)
| |
Lipid profile in COPD patients with coronary artery disease comorbidity
O. Krakhmalova, O. Hetman (Kharkiv, Ukraine)
| |
Outcomes of COPD exacerbations - a report from the ERS COPD audit in Austria
R. Breyer-Kohansal, M. K. Breyer, O. Burghuber, S. Hartl (Vienna, Austria)
|  |
24-hour arterial stiffness monitoring values in patients with COPD
N. Karoli, G. Dolishnyaya, A. Rebrov (Saratov, Russian Federation)
| |
Osteoporosis and adipose tissue expression of adipokines and osteoprotegerin in severe chronic obstructive pulmonary disease
E. Kochetkova, V. Nevzorova, L. Ugay, E. Kotciurbii (Vladivostok, Russian Federation)
| |
Efficacy of a special COPD consultation in reducing hospital admissions and emergency room visits
A. Fuster, L. Chacon, J. Bauza, S. Torres, I. Mir (Palma de Mallorca, Spain)
| |
Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey
Y. Chen, W. Yao, J. Kang, B. Cai, X. Zhou, Z. Liu, P. Chen, D. Sun, J. Zheng, G. Wang, Y. Feng, Y. Xu (Beijing, Shenyang, Shanghai, Langfang, Baotou, Guangzhou, Wuhan, China)
| |
Cardiovascular events (CVE) in COPD patients
S. Avdeev, G. Baimakanova, A. Chuchalin (Moscow, Russian Federation)
| |
Medication prescribing for COPD in primary care databases
S. Brill, E. El-Emir, J. Allinson, A. Mackay, R. Singh, A. Patel, G. Donaldson, I. Nazareth, J. Wedzicha (London, United Kingdom)
| |
Importance of the initial behaviour of patients in avoiding late recovery from COPD exacerbations
T. Motegi, T. Ishii, K. Hattori, Y. Kusunoki, R. Furutate, A. Gemma, K. Kida (Tokyo, Japan)
| |
Can we diagnose COPD by just asking 8 questions?
S. Bardapurkar, S. Bardapurkar, G. Gadge (Aurangabad, India)
| |
Prevalence of comorbidities in patients with COPD: Data from the TOPDOCS cohort
C. F. Clarenbach, N. A. Sievi, T. Brack, M. Brutsche, M. Frey, S. Irani, J. Leuppi, J. Ruediger, O. Senn, R. Thurnheer, M. Kohler (Zurich, Glarus, St. Gallen, Barmelweid, Aarau, Basel, Muensterlingen, Switzerland)
| |
Can antibiotics prevent acute COPD exacerbation? A systematic review and meta-analysis
H. Riaz, T. Abir, M. Rahman, A. Rehman, A. Kapadia, T. Riaz (Karachi, Pakistan; Sydney, Australia)
| |
The impact of implementing a COPD care bundle on the delivery of care to patients admitted with an acute exacerbation of COPD
S. Davies, S. Packham, S. Dyer, M. Davies, L. Johnstone, S. Lloyd (Swansea, United Kingdom)
| |